To continue reading this content, please enable JavaScript in your browser settings and refresh this page. Preview this article 1 min Dr. Carl June and Bruce Levine ...
This year will be regarded as an inflection point for the treatment of glioblastoma, a rare and aggressive form of brain cancer that carries a median survival time of around 15 to 18 months, said Carl ...